Sonja Primassin
Research Subjects
Sonja Primassin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Sara Tucci
2 shared publicationsUte Spiekerkoetter
2 shared publicationsAnnette Seibt
Department of General Pediatrics University Children's Hospital Moorenstraße 5 Duesseldorf 40225 Germany
1 shared publication- Diran Herebian
Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
1 shared publication Frank ter Veld
Department of General Pediatrics University Children's Hospital Moorenstraße 5 Duesseldorf 40225 Germany
1 shared publicationLars Hoffmann
Department of General Pediatrics University Children's Hospital Moorenstraße 5 Duesseldorf 40225 Germany
1 shared publication
Latest Publications
- 1 December 2011
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 104 (4) , 546-551
Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice
- 1 December 2011
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 104 (4) , 546-551
Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice
- 1 October 2010
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 101 (2-3) , 141-145
ESI-MS/MS measurement of free carnitine and its precursor γ-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders
- 1 October 2010
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 101 (2-3) , 141-145
ESI-MS/MS measurement of free carnitine and its precursor γ-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders
- 6 May 2010
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (3) , 237-246
Pre‐exercise medium‐chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very‐long‐chain acyl‐CoA‐dehydrogenase‐deficient mice
Dietary modification with medium‐chain triglyceride (MCT) supplementation is one crucial way of treating children with long‐chain fatty acid oxidation disorders. Recently, supplementation prior to exercise has been reported to prevent muscular pain and rhabdomyolysis. Systematic studies to determine when MCT supplementation is most beneficial have not yet been undertaken. We studied the effects of an MCT‐based diet compared with MCT administration only prior to exercise in very‐long‐chain acyl‐CoA dehydrogenase (VLCAD) knockout (KO) mice. VLCAD KO mice were fed an MCT‐based diet in same amounts as normal mouse diet containing long‐chain triglycerides (LCT) and were exercised on a treadmill. Mice fed a normal LCT diet received MCT only prior to exercise. Acylcarnitine concentration, free carnitine concentration, and acyl‐coenzyme A (CoA) oxidation capacity in skeletal muscle as well as hepatic lipid accumulation were determined. Long‐chain acylcarnitines significantly increased in VLCAD‐deficient skeletal muscle with an MCT diet compared with an LCT diet with MCT bolus prior to exercise, whereas an MCT bolus treatment significantly decreased long‐chain acylcarnitines after exercise compared with an LCT diet. C8‐carnitine was significantly increased in skeletal muscle after MCT bolus treatment and exercise compared with LCT and long‐term MCT treatment. Increased hepatic lipid accumulation was observed in long‐term MCT‐treated KO mice. MCT seems most beneficial when given in a single dose directly prior to exercise to prevent acylcarnitine accumulation. In contrast, continuous MCT treatment produces a higher skeletal muscle content of long‐chain acylcarnitines after exercise and increases hepatic lipid storage in VLCAD KO mice.
- 6 May 2010
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (3) , 237-246
Pre‐exercise medium‐chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very‐long‐chain acyl‐CoA‐dehydrogenase‐deficient mice
Dietary modification with medium‐chain triglyceride (MCT) supplementation is one crucial way of treating children with long‐chain fatty acid oxidation disorders. Recently, supplementation prior to exercise has been reported to prevent muscular pain and rhabdomyolysis. Systematic studies to determine when MCT supplementation is most beneficial have not yet been undertaken. We studied the effects of an MCT‐based diet compared with MCT administration only prior to exercise in very‐long‐chain acyl‐CoA dehydrogenase (VLCAD) knockout (KO) mice. VLCAD KO mice were fed an MCT‐based diet in same amounts as normal mouse diet containing long‐chain triglycerides (LCT) and were exercised on a treadmill. Mice fed a normal LCT diet received MCT only prior to exercise. Acylcarnitine concentration, free carnitine concentration, and acyl‐coenzyme A (CoA) oxidation capacity in skeletal muscle as well as hepatic lipid accumulation were determined. Long‐chain acylcarnitines significantly increased in VLCAD‐deficient skeletal muscle with an MCT diet compared with an LCT diet with MCT bolus prior to exercise, whereas an MCT bolus treatment significantly decreased long‐chain acylcarnitines after exercise compared with an LCT diet. C8‐carnitine was significantly increased in skeletal muscle after MCT bolus treatment and exercise compared with LCT and long‐term MCT treatment. Increased hepatic lipid accumulation was observed in long‐term MCT‐treated KO mice. MCT seems most beneficial when given in a single dose directly prior to exercise to prevent acylcarnitine accumulation. In contrast, continuous MCT treatment produces a higher skeletal muscle content of long‐chain acylcarnitines after exercise and increases hepatic lipid storage in VLCAD KO mice.